MARKETSACTIVE
25 mins ago · China
F.D.A. Rejects Closely Watched Lung Cancer Drug From China
What's happening
SignalsMonitor is following this as a markets story. New York Times Business is the outlet attached so far. The reports are tied to China. The first report grouped here was at 15 Nov 2026, 20:33 UTC. The headline in use is “F.D.A. Rejects Closely Watched Lung Cancer Drug From China”. This note is SignalsMonitor's own briefing, not the publisher's article.
What we know
The treatment, called ivonescimab, has become a symbol of China’s rise in drug development.
New York Times BusinessRead at New York Times Business
Story timeline
Reports grouped into this story, earliest first. Exact repeats from the same outlet are collapsed.
- First reported by New York Times Business
Reported by 1 outlet
- The New York Times
- The New York TimesF.D.A. Rejects Closely Watched Lung Cancer Drug From China